Table 4

Hippocampal gene expression following treatment with TIMP2 and TIMP2-hIgG4

ModalityGeneVehicleTIMP2TIMP2-hIgG4
NeuronalDcx1 ± 0.0380.924 ± 0.0591.169 ± 0.077
Tubb31 ± 0.0301.032 ± 0.0191.087 ± 0.031
Syn11 ± 0.0410.865 ± 0.0231.060 ± 0.048
Dlg41 ± 0.0380.879 ± 0.0320.953 ± 0.048
Gria11 ± 0.0511.050 ± 0.0850.870 ± 0.087
Grin2a1 ± 0.0360.977 ± 0.0550.890 ± 0.039
Slc2a11 ± 0.0350.906 ± 0.0261.056 ± 0.041
Gad11 ± 0.0331.059 ± 0.0390.0919 ± 0.071
Immediate
early
genes
Cfos1 ± 0.0281.421 ± 0.1361.923 ± 0.357
Creb11 ± 0.0271.052 ± 0.0240.940 ± 0.057
Egr11 ± 0.0731.089 ± 0.0681.387 ± 0.192
MicrogliaCd681 ± 0.0851.096 ± 0.0800.955 ± 0.053
Iba11 ± 0.0610.950 ± 0.0600.960 ± 0.079
Cd11b1 ± 0.0571.176 ± 0.1190.903 ± 0.110
InflammatoryIl1a1 ± 0.0891.086 ± 0.0710.938 ± 0.105
Il1b1 ± 0.2390.884 ± 0.1380.775 ± 0.184
Il61 ± 0.1050.906 ± 0.0690.913 ± 0.085
Ccl111 ± 0.0771.174 ± 0.0720.987 ± 0.080
Nfkb1 ± 0.0390.960 ± 0.0530.879 ± 0.060
Tnfa1 ± 0.1190.874 ± 0.1410.878 ± 0.108
AstrocytesGfap1 ± 0.0711.025 ± 0.0710.879 ± 0.078
Aqp41 ± 0.0421.067 ± 0.0630.850 ± 0.079
Ggta11 ± 0.0661.031 ± 0.0360.809 ± 0.095
  • Average gene expression relative to Gapdh measured by Taqman or SYBR qPCR from bulk hippocampal tissue for each treatment group. n = 9–13 mice per group. All data are shown as mean ± SEM.